Evidence map›Paper›PMID 42143208›Full record

SynthesisSports medicine (Auckland, N.Z.)2026

Coronary Artery Disease in Masters Athletes: A Systematic Review.

Shaqira Gill, Kabir Singh, Nikos Malliaropoulos, Evangelia Kouidi

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Sports medicine (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaqira GillBarts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AD, UK.ORCID http://orcid.org/0009-0008-5254-3636
Kabir SinghImperial College Healthcare NHS Trust, London, W2 1NY, UK. ksingh4@ic.ac.uk.ORCID http://orcid.org/0000-0001-8536-6906
Nikos MalliaropoulosCentre for Sports and Exercise Medicine, Queen Mary University of London, London, E1 4DG, UK.ORCID http://orcid.org/0000-0002-5220-8992
Evangelia KouidiLaboratory of Sports Medicine, Department of Physical Education and Sports Science, Aristotle University of Thessaloniki, 57001, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-5023-2542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite undertaking large volumes of structured exercise training, evidence suggests that masters athletes (MAs) remain susceptible to coronary artery disease (CAD). This review evaluated the prevalence and nature of CAD in MAs.

methodsPubMed, Medline, EMBASE, Web of Science and Cochrane Library were searched on 23 November 2024, from 1 January 2000. MAs were defined as apparently healthy individuals aged ≥ 35 years with an exercise training history indicative of regular engagement in sporting activity. The Appraisal tool for Cross-Sectional Studies (AXIS) was used to assess study quality.

resultsA total of 17 studies reporting various measures of CAD in 2749 MAs (2127 male, 622 female) were included. Coronary artery calcium (CAC) was present in a significant proportion, with 565 MAs scoring > 0, and 179 and 43 MAs exceeding thresholds of > 100 and > 400, respectively. Evidence of plaque was detected in at least 458 MAs. This was predominantly calcified in the majority of cases. Obstructive disease (> 50% stenosis) was also identified in at least 51 MAs. Conventional cardiovascular (CV) risk factors such as smoking, dyslipidaemia, hypertension and diabetes were prevalent in this population. DISCUSSION: Clinical and methodological heterogeneity made it challenging to perform accurate quantitative analyses. However, our data reiterate that MAs are not invulnerable to CAD. Long-term and high-intensity endurance training may be associated with changes that predispose to atherosclerotic disease. Female MAs, and those from low- and middle-income countries, are markedly underrepresented in literature.

conclusionA more individualised approach to CV risk assessment may be warranted in the future to guide early CAD detection and subsequent management. REGISTRATION: PROSPERO 2024 CRD42024607539.

Indexed as

AthletesCoronary Artery DiseaseFemaleHumansPrevalenceRisk Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.